CAS No. 1448169-71-8
Batch:
Purity:99.92
Chemical Structure
Check the
Futibatinib (TAS-120)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 1-[(3S)-3-[4-amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]pyrazolo[3,4-d]pyrimidin-1-yl]pyrrolidin-1-yl]prop-2-en-1-one | |
|---|---|---|
| CAS Number | 1448169-71-8 | |
| Molecular Formula |
C22H22N6O3 |
|
| Molecular Weight (MW) | 418.45 | |
| SMILES | COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC | |
| InChIKey | KEIPNCCJPRMIAX-HNNXBMFYSA-N |
Futibatinib (TAS-120) is an irreversible inhibitor of fibroblast growth factor receptors, targeting FGFR1, FGFR2 (IC50 1.4 nM), FGFR3, and FGFR4 (IC50 3.7 nM). By covalently binding to the ATP-binding pocket of FGFRs, it suppresses receptor autophosphorylation and downstream signaling pathways. Consequently, futibatinib inhibits cell proliferation and selectively induces cell death in cancer cell lines carrying FGFR genomic alterations. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
84 mg/mL
(200.74 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(200.74 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(200.74 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Futibatinib (TAS-120) Clinical Trials
- Futibatinib (TAS-120) Solubility in DMSO
- Futibatinib (TAS-120) Stock Solution
- Futibatinib (TAS-120) Storage
- Futibatinib (TAS-120) Stability
- Futibatinib (TAS-120) Molecular Weight
- Futibatinib (TAS-120) SMILES
- Futibatinib (TAS-120) Chemical Structure (2D and 3D)
- Futibatinib (TAS-120) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.